41 related articles for article (PubMed ID: 1545394)
1. Cardiac responses and binding sites for endothelin in normal and cardiomyopathic hamsters.
Bolger GT; Berry R; Liard F; Garneau M; Jaramillo J
J Pharmacol Exp Ther; 1992 Mar; 260(3):1314-22. PubMed ID: 1545394
[TBL] [Abstract][Full Text] [Related]
2. Activity of the L-arginine/nitric oxide pathway and endothelin-1 in experimental heart failure.
Noll G; Tschudi MR; Novosel D; Lüscher TF
J Cardiovasc Pharmacol; 1994 Jun; 23(6):916-21. PubMed ID: 7523783
[TBL] [Abstract][Full Text] [Related]
3. The positive inotropic effect and the hydrolysis of phosphoinositide induced by endothelin-3 in rabbit ventricular myocardium: inhibition by a selective antagonist of ET(A) receptors, FR139317.
Endoh M; Norota I; Yang HT; Fujita S; Takanashi M
J Pharmacol Exp Ther; 1996 Apr; 277(1):61-70. PubMed ID: 8613968
[TBL] [Abstract][Full Text] [Related]
4. Contractile and arrhythmic effects of endothelin receptor agonists in human heart in vitro: blockade with SB 209670.
Burrell KM; Molenaar P; Dawson PJ; Kaumann AJ
J Pharmacol Exp Ther; 2000 Jan; 292(1):449-59. PubMed ID: 10604982
[TBL] [Abstract][Full Text] [Related]
5. Positive inotropic effect of endothelin-2 on human atrium preparations in vitro.
Poli E; Barboso G; Casoli C; Starcich R; Bertaccini G
Cardioscience; 1991 Jun; 2(2):99-104. PubMed ID: 1652300
[TBL] [Abstract][Full Text] [Related]
6. Determination of endothelin binding sites in bovine atrium and ventricle membranes: a model for binding studies in human cardiac tissue.
Del RY S; Andreassi MG; Lazzerini G; Iervasi G; Clerico A; Biagini A; Giannessi D
Int J Tissue React; 1995; 17(3):117-24. PubMed ID: 8867651
[TBL] [Abstract][Full Text] [Related]
7. Increased endothelin-1 binding sites in the cardiac membranes in rats with chronic heart failure.
Miyauchi T; Sakai S; Ihara M; Kasuya Y; Yamaguchi I; Goto K; Sugishita Y
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S448-51. PubMed ID: 8587442
[TBL] [Abstract][Full Text] [Related]
8. Angiotensins and the failing heart. Enhanced positive inotropic response to angiotensin I in cardiomyopathic hamster heart in the presence of captopril.
Hirakata H; Fouad-Tarazi FM; Bumpus FM; Khosla M; Healy B; Husain A; Urata H; Kumagai H
Circ Res; 1990 Apr; 66(4):891-9. PubMed ID: 2180588
[TBL] [Abstract][Full Text] [Related]
9. Subcellular mechanism of the species difference in the contractile response of ventricular myocytes to endothelin-1.
Del Monte F; Mynett JR; Sugden PH; Poole-Wilson PA; Harding SE
Cardioscience; 1993 Sep; 4(3):185-91. PubMed ID: 8400027
[TBL] [Abstract][Full Text] [Related]
10. Tension-frequency relationships in normal and cardiomyopathic dog and hamster myocardium.
Li K; Rouleau JL
J Mol Cell Cardiol; 1995 Jun; 27(6):1251-61. PubMed ID: 8531207
[TBL] [Abstract][Full Text] [Related]
11. Influence of congestive heart failure on endothelin levels and receptors in rabbits.
Löffler BM; Roux S; Kalina B; Clozel M; Clozel JP
J Mol Cell Cardiol; 1993 Apr; 25(4):407-16. PubMed ID: 8340932
[TBL] [Abstract][Full Text] [Related]
12. Age related changes in contractility and alpha 1 adrenergic responsiveness of myocardium from normal hamsters and hamsters with hereditary cardiomyopathy.
Li K; Rouleau JL
Cardiovasc Res; 1993 Jun; 27(6):968-73. PubMed ID: 8221787
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological analysis of the cardiac actions of xamoterol, a beta adrenoceptor antagonist with partial agonistic activity, in guinea pig heart: evidence for involvement of adenylate cyclase system in its cardiac stimulant actions.
Hattori Y; Sakuma I; Nakao Y; Kanno M
J Pharmacol Exp Ther; 1987 Sep; 242(3):1077-85. PubMed ID: 2888870
[TBL] [Abstract][Full Text] [Related]
14. Inotropic effects of endothelin on mammalian ventricular contractility.
Endoh M; Takanashi M
Basic Res Cardiol; 1991; 86 Suppl 1():173-8. PubMed ID: 2036090
[TBL] [Abstract][Full Text] [Related]
15. Endothelin ETA receptors and endothelium partially mediate the positive inotropic and lusitropic effects of angiotensin II.
Castro-Chaves P; Roncon-Albuquerque R; Leite-Moreira AF
Eur J Pharmacol; 2006 Aug; 544(1-3):91-6. PubMed ID: 16842775
[TBL] [Abstract][Full Text] [Related]
16. Vascular and cardiac effects of a new dihydropyridine derivative, YC-170: a comparison with Bay K 8644.
Hattori Y; Nakaya H; Tohse N; Kanno M
J Pharmacol Exp Ther; 1986 Aug; 238(2):670-8. PubMed ID: 2426442
[TBL] [Abstract][Full Text] [Related]
17. Cardiac adenylate cyclase activity, positive chronotropic and inotropic effects of forskolin analogs with either low, medium or high binding site affinity.
Hubbard JW; Conway PG; Nordstrom LC; Hartman HB; Lebedinsky Y; O'Malley GJ; Kosley RW
J Pharmacol Exp Ther; 1991 Feb; 256(2):621-7. PubMed ID: 1993999
[TBL] [Abstract][Full Text] [Related]
18. Effects of cholinomimetic drugs on reptilian atrial muscles.
Ojewole JA; Akinwande KI
Methods Find Exp Clin Pharmacol; 1984 Jul; 6(7):379-87. PubMed ID: 6503473
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the endothelin binding site on bovine adrenomedullary chromaffin cells: comparison with vascular smooth muscle cells. Evidence for receptor heterogeneity.
Wilkes LC; Boarder MR
J Pharmacol Exp Ther; 1991 Feb; 256(2):628-33. PubMed ID: 1847205
[TBL] [Abstract][Full Text] [Related]
20. Species-dependent differences in inotropic effects and phosphoinositide hydrolysis induced by endothelin-3 in mammalian ventricular myocardium.
Yang HT; Zhu Y; Endoh M
Br J Pharmacol; 1997 Apr; 120(8):1497-504. PubMed ID: 9113371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
